Specific immunosuppression, polyinosinic--polycytidylic acid, and viruses in New Zealand mice.
D000406:AKR murine leukemia virus / Q000276:immunology; D000818:Animals; D000918:Antibody Specificity; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D002247:Carbon Isotopes; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D005620:Freund's Adjuvant; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007125:Immunogenetics; D007165:Immunosuppression Therapy; D009052:Leukemia Virus, Murine / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000276:immunology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008979:Moloney murine leukemia virus / Q000276:immunology; D009160:Mycobacteriophages / Q000276:immunology; D011070:Poly I-C; D012313:RNA; D012367:RNA, Viral; D012087:Reoviridae / Q000276:immunology; D013045:Species Specificity; D014316:Tritium
D000956:Antigens, Viral; D002247:Carbon Isotopes; D012367:RNA, Viral; D014316:Tritium; D012313:RNA; D003520:Cyclophosphamide; D005620:Freund's Adjuvant; D011070:Poly I-C